Kuangli Bio-Tech Holdings Co. Ltd. (6431) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kuangli Bio-Tech Holdings Co. Ltd. (6431:TWSE), powered by AI.

Current Price
$19.50
Sector
Consumer Defensive
What is the Kuangli Bio-Tech Holdings Co. Ltd. stock price forecast?

Kuangli Bio-Tech Holdings Co. Ltd. is currently trading at $19.50. View real-time AI analysis on Alpha Lenz.

What is Kuangli Bio-Tech Holdings Co. Ltd. insider trading activity?

View the latest insider trading data for Kuangli Bio-Tech Holdings Co. Ltd. on Alpha Lenz.

What is Kuangli Bio-Tech Holdings Co. Ltd.'s P/E ratio?

View Kuangli Bio-Tech Holdings Co. Ltd.'s valuation metrics on Alpha Lenz.

Kuangli Bio-Tech Holdings Co. Ltd.

TWSE · 6431
NT$19.50+0.80(+4.28%)
Ask about Kuangli Bio-Tech Holdings Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Kuangli Bio-Tech Holdings Co. Ltd.'s ROE is -37.2%. Explore profitability and growth together.

Ask for details

Company Overview

Kuangli Bio-Tech Holdings Co. Ltd. is a company engaged in the biotechnology sector, focusing on the research, development, and production of health-related products. It plays a significant role in the life sciences industry, offering a portfolio that spans across pharmaceuticals, nutraceuticals, and various bioactive compounds. Kuangli Bio-Tech's primary function is to enhance health and wellness through innovative biotechnology solutions. The company’s products often impact sectors such as healthcare, agriculture, and environmental sciences, demonstrating versatility and adaptability in meeting diverse industry needs. In the financial market, Kuangli Bio-Tech Holdings Co. Ltd. stands out as a dynamic player capitalizing on the growing demand for biotechnology-based advancements. By investing in cutting-edge research and development, the company contributes to the development of new solutions aimed at addressing global health challenges, thus holding a strong position within the biotechnology landscape.

SectorConsumer Defensive
IndustryHousehold & Personal Products
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$377.03MRevenue
0.00Shares Out
0Employees

Margins

18.68%Gross
-22.17%EBITDA
-39.42%Operating
-51.20%Pre-Tax
-51.20%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.29%Rev 3Yr
34.09%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-18.41%ROA
-37.21%ROE
-17.10%ROIC

Financial Health

NT$208.93MCash & Cash Equivalents
NT$398.08MNet Debt
104.60%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kuangli Bio-Tech Holdings Co. Ltd. (ticker: 6431) is a company listed on TWSE in the Consumer Defensive sector (Household & Personal Products).

The current price is 19.5 with a P/E ratio of -x and P/B of -x.

ROE is -37.21% and operating margin is -39.42%. Annual revenue is $377M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kuangli Bio-Tech Holdings Co. Ltd. (6431) Stock Forecast 2026 $19.50 — Price, Financials & Analyst Targets | Alpha Lenz